Investment Opportunities
Centrose is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer. The Company is headquartered in Madison, Wisconsin, and began operations in 2007. Centrose discovered the first Extracellular Drug Conjugate platform, which has the potential to revolutionize targeted drug discovery. Our leadership team has years of experience at successfully running and selling biotechnology companies.
The Centrose business plan is centered around producing patented EDC drug candidates in large markets where the need for new drugs persists, then to license those products to publicly-traded companies. To do this, Centrose is moving quickly to send its first oncology lead into clinical trials. Centrose outsources manufacturing to a well-established CMO and concentrates its resources on discovering new drug leads, advancing the EDC system and securing assets.
The Centrose business model aims to fill a void in the Pharmaceutical Industry’s new drug pipeline and to prudently initiate partnerships for its EDC system. This strategy is in line with industry expectations, lowers risk and increases revenues. We believe that our broadly-applicable technology will play a major role in life-enhancing, new product discoveries, enabling rapid and sustained growth for Centrose.
